Retirement Systems of Alabama Sells 458 Shares of Align Technology, Inc. $ALGN

Retirement Systems of Alabama cut its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 3.0% in the second quarter, HoldingsChannel reports. The firm owned 14,621 shares of the medical equipment provider’s stock after selling 458 shares during the period. Retirement Systems of Alabama’s holdings in Align Technology were worth $2,768,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of ALGN. Cromwell Holdings LLC raised its position in shares of Align Technology by 2,900.0% in the 2nd quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 174 shares in the last quarter. SVB Wealth LLC bought a new position in shares of Align Technology in the 1st quarter worth $36,000. Farther Finance Advisors LLC raised its position in shares of Align Technology by 42.2% in the 2nd quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock worth $59,000 after acquiring an additional 92 shares in the last quarter. Covestor Ltd raised its position in shares of Align Technology by 18.8% in the 1st quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock worth $78,000 after acquiring an additional 78 shares in the last quarter. Finally, Assetmark Inc. raised its position in shares of Align Technology by 327.6% in the 2nd quarter. Assetmark Inc. now owns 449 shares of the medical equipment provider’s stock worth $85,000 after acquiring an additional 344 shares in the last quarter. 88.43% of the stock is owned by institutional investors.

Align Technology Stock Performance

Align Technology stock opened at $137.21 on Thursday. The business’s 50-day simple moving average is $132.89 and its two-hundred day simple moving average is $161.10. The company has a market cap of $9.95 billion, a PE ratio of 26.59, a PEG ratio of 1.49 and a beta of 1.70. Align Technology, Inc. has a fifty-two week low of $122.00 and a fifty-two week high of $246.19.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.23. The business had revenue of $995.69 million for the quarter, compared to the consensus estimate of $980.75 million. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.The company’s quarterly revenue was up 1.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.35 EPS. Align Technology has set its Q4 2025 guidance at EPS. As a group, analysts predict that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Align Technology announced that its board has authorized a stock buyback plan on Tuesday, August 5th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to reacquire up to 2% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Leerink Partners boosted their price target on Align Technology from $172.00 to $189.00 in a research report on Thursday, October 30th. Piper Sandler reissued an “overweight” rating and issued a $200.00 price target (up from $190.00) on shares of Align Technology in a research report on Thursday, October 30th. Weiss Ratings lowered Align Technology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, October 8th. Evercore ISI boosted their price target on Align Technology from $160.00 to $170.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Finally, Stifel Nicolaus set a $200.00 target price on Align Technology in a research note on Thursday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $175.45.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.